פריוריקס טטרה

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

LIVE ATTENUATED MEASLES VIRUS; LIVE ATTENUATED MUMPS VIRUS; LIVE ATTENUATED RUBELLA VIRUS; LIVE ATTENUATED VARICELLA VIRUS

Disponible depuis:

GLAXO SMITH KLINE (ISRAEL) LTD

Code ATC:

J07BD54

forme pharmaceutique:

אבקה וממס להכנת תמיסה להזרקה

Composition:

LIVE ATTENUATED MEASLES VIRUS 10^ 3.0 CCID50; LIVE ATTENUATED MUMPS VIRUS 10^ 4.4 CCID50; LIVE ATTENUATED RUBELLA VIRUS 10^ 3.0 CCID50; LIVE ATTENUATED VARICELLA VIRUS 10^ 3.3 PFU

Mode d'administration:

תת-עורי

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

GLAXO SMITH KLINE BIOLOGICALS S.A

Groupe thérapeutique:

MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED

Domaine thérapeutique:

MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED

indications thérapeutiques:

Priorix-Tetra is indicated for active immunisation against measles, mumps, rubella and varicella in children from the age of 12 months up and including 12 years of age.

Date de l'autorisation:

2023-07-31